OpenURL Connection Search

Select item for more details and to access through your institution.

The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibition.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1295185
By:
- Vanneste, Marion;
- Venzke, Anita;
- Guin, Soumitra;
- Fuller, Andrew J.;
- Jezewski, Andrew J.;
- Beattie, Sarah R.;
- Krysan, Damian J.;
- Meyers, Marvin J.;
- Henry, Michael D.
Publication type:
Article
Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy.
Published in:
Cancers, 2021, v. 13, n. 7, p. 1489, doi. 10.3390/cancers13071489
By:
- Rieth, John M.;
- Swami, Umang;
- Mott, Sarah L.;
- Zanaty, Mario;
- Henry, Michael D.;
- Bossler, Aaron D.;
- Greenlee, Jeremy D.;
- Zakharia, Yousef;
- Vanneste, Marion;
- Jennings, Brooke;
- Milhem, Mohammed M.;
- Moulin, Alexandre;
- Michielin, Olivier
Publication type:
Article
Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging.
Published in:
PLoS ONE, 2020, v. 15, n. 9, p. 1, doi. 10.1371/journal.pone.0232807
By:
- Yong, Courtney;
- Moose, Devon L.;
- Bannick, Nadine;
- Gutierrez, Wade R.;
- Vanneste, Marion;
- Svensson, Robert;
- Breheny, Patrick;
- Brown, James A.;
- Dodd, Rebecca D.;
- Cohen, Michael B.;
- Henry, Michael D.
Publication type:
Article
Anatomical and behavioral impact of a lentiviral tool tapping onto hippocampal serotonin reuptake in rats.
Published in:
Synapse, 2020, v. 74, n. 4, p. 1, doi. 10.1002/syn.22138
By:
- Zoratto, Francesca;
- Buccheri, Clelia;
- Mura, Romina;
- Altabella, Luisa;
- Vanneste, Marion;
- Villotte, Marie;
- Laviola, Giovanni;
- Dauphin, Francois;
- Paizanis, Eleni;
- Adriani, Walter;
- Canese, Rossella
Publication type:
Article
SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas.
Published in:
NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00310-7
By:
- Zhu, Eliot Y.;
- Riordan, Jesse D.;
- Vanneste, Marion;
- Henry, Michael D.;
- Stipp, Christopher S.;
- Dupuy, Adam J.
Publication type:
Article
High content screening identifies monensin as an EMT-selective cytotoxic compound.
Published in:
Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-38019-y
By:
- Vanneste, Marion;
- Huang, Qin;
- Li, Mengshi;
- Moose, Devon;
- Zhao, Lei;
- Stamnes, Mark A.;
- Schultz, Michael;
- Wu, Meng;
- Henry, Michael D.
Publication type:
Article
Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis.
Published in:
Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00442
By:
- Vanneste, Marion;
- Feddersen, Charlotte R.;
- Varzavand, Afshin;
- Zhu, Elliot Y.;
- Foley, Tyler;
- Zhao, Lei;
- Holt, Kathleen H.;
- Milhem, Mohammed;
- Piper, Robert;
- Stipp, Christopher S.;
- Dupuy, Adam J.;
- Henry, Michael D.
Publication type:
Article

Found: 7

The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibition.

Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy.

Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging.

Anatomical and behavioral impact of a lentiviral tool tapping onto hippocampal serotonin reuptake in rats.

SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas.

High content screening identifies monensin as an EMT-selective cytotoxic compound.

Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling Axis.